Internal Medicine, Hematology & Oncology · Los Angeles, CA
NPI
1992999031
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1700 E. Cesar Chavez Ave, Suite 3500
Los Angeles, CA, 90033
Phone (323) 264-0430
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,699
717 services
Medicare patients, 2024
25
Average age 69
Drug cost, 2024
$19.2M
4,658 prescriptions
Company payments, 2025
$46K
From 41 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rahul R Naik was code 99442 (telephone services), 42 times for 14 patients. In total Rahul R Naik billed 717 services in 23 codes, and Medicare paid $5,699.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99442 Telephone Services | Office | 42 | 14 | $66.24 | $2,782 |
| 99213 Office E&M - Established | Office | 29 | 11 | $66.85 | $1,939 |
By year: 2022 $36K for 2,193 services; 2023 $15K for 769 services; 2024 $5,699 for 717 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rahul R Naik prescribed most often to Medicare patients was Anastrozole, with 531 prescriptions and refills. In total Rahul R Naik wrote 4,658 Medicare prescriptions that cost $19.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 531 | 1,012 | 139 | $6,514 |
| Ondansetron Hcl Generic | 229 | 229 | 131 | $15K |
| Prochlorperazine Maleate Generic | 195 | 195 | 123 | $2,233 |
| Orgovyx Relugolix | 188 | 188 | 25 | $498K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 177 | 177 | 74 | $3,308 |
| Letrozole Generic | 172 | 270 | 44 | $1,966 |
| Hydroxyurea Generic | 161 | 259 | 37 | $2,313 |
| Zarxio Filgrastim-Sndz | 149 | 149 | 43 | $122K |
| Eliquis Apixaban | 132 | 157 | 31 | $87K |
| Dexamethasone Generic | 131 | 136 | 69 | $2,113 |
| Prednisone Generic | 110 | 113 | 30 | $367 |
| Exemestane Generic | 104 | 138 | 29 | $11K |
| Procrit Epoetin Alfa | 85 | 85 | 25 | $126K |
| Revlimid Lenalidomide | 80 | 80 | Under 11 | $1.6M |
| Abiraterone Acetate Generic | 77 | 77 | 13 | $107K |
Brand drugs: 1,849 claims; generic drugs: 2,809 claims; opioid claims: 301.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rahul R Naik $46K ($46K in general payments such as food, travel and fees) from 41 companies. The largest payer was GlaxoSmithKline, LLC. with $20K.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 22 | $20K |
| Karyopharm Therapeutics Inc. KPTI | 9 | $15K |
| Exelixis Inc. EXEL | 11 | $2,678 |
| Janssen Biotech, Inc. JNJ | 11 | $2,441 |
| Pfizer Inc. PFE | 15 | $1,537 |
| AstraZeneca Pharmaceuticals LP AZN | 18 | $442 |
| Merck Sharp & Dohme LLC MRK | 12 | $365 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $263 |
| Array Biopharma Inc PFE | 14 | $234 |
| E.R. Squibb & Sons, L.L.C. BMY | 16 | $203 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.